Literature DB >> 18725574

CD4 T cells: fates, functions, and faults.

Jinfang Zhu1, William E Paul.   

Abstract

In 1986, Mosmann and Coffman identified 2 subsets of activated CD4 T cells, Th1 and Th2 cells, which differed from each other in their pattern of cytokine production and their functions. Our understanding of the importance of the distinct differentiated forms of CD4 T cells and of the mechanisms through which they achieve their differentiated state has greatly expanded over the past 2 decades. Today at least 4 distinct CD4 T-cell subsets have been shown to exist, Th1, Th2, Th17, and iTreg cells. Here we summarize much of what is known about the 4 subsets, including the history of their discovery, their unique cytokine products and related functions, their distinctive expression of cell surface receptors and their characteristic transcription factors, the regulation of their fate determination, and the consequences of their abnormal activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725574      PMCID: PMC2518872          DOI: 10.1182/blood-2008-05-078154

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  179 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Selective expression of a novel surface molecule by human Th2 cells in vivo.

Authors:  K Nagata; K Tanaka; K Ogawa; K Kemmotsu; T Imai; O Yoshie; H Abe; K Tada; M Nakamura; K Sugamura; S Takano
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

3.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice.

Authors:  R L Coffman; B W Seymour; S Hudak; J Jackson; D Rennick
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

4.  The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines.

Authors:  J I Kim; I C Ho; M J Grusby; L H Glimcher
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

5.  Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis.

Authors:  H Mitsuyasu; Y Yanagihara; X Q Mao; P S Gao; Y Arinobu; K Ihara; A Takabayashi; T Hara; T Enomoto; S Sasaki; M Kawai; N Hamasaki; T Shirakawa; J M Hopkin; K Izuhara
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

6.  Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells.

Authors:  L Killar; G MacDonald; J West; A Woods; K Bottomly
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

7.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

8.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

9.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.

Authors:  G Le Gros; S Z Ben-Sasson; R Seder; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  580 in total

1.  Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Authors:  Josie Ursini-Siegel; Sean Cory; Dongmei Zuo; William R Hardy; Elton Rexhepaj; Sonya Lam; Babette Schade; Karin Jirstrom; Eva Bjur; Ciriaco A Piccirillo; David Denardo; Lisa M Coussens; Donal J Brennan; William M Gallagher; Morag Park; Tony Pawson; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

3.  Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells.

Authors:  Gucheng Zeng; Crystal Y Chen; Dan Huang; Shuyu Yao; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

4.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 5.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

Review 6.  Gene polymorphisms: the keys for marker assisted selection and unraveling core regulatory pathways for mastitis resistance.

Authors:  Gina M Pighetti; A A Elliott
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-14       Impact factor: 2.673

Review 7.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

Review 8.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

9.  Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Authors:  Cemile Sonmez; Aysegul Atak Yucel; Turan Hilmi Yesil; Hamit Kucuk; Berna Sezgin; Ridvan Mercan; Ahmet Eftal Yucel; Gulderen Yanikkaya Demirel
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

10.  Temporal requirements for B cells in the establishment of CD4 T cell memory.

Authors:  Sarah B Mollo; Allan J Zajac; Laurie E Harrington
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.